Aktie A3EFQ9 FINCH THERAPEUTICS GROUP, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Finch Therapeutics Group, Inc.

Aktien

A3EFQ9

US31773D2009

FNCH

Markt geschlossen - Nasdaq
Andere Börsenplätze
 22:30:00 30.04.2024 		% 5 Tage % 1. Jan.
2.24 USD -2.61% Intraday Chart für Finch Therapeutics Group, Inc. -19.68% -37.95%
25.03. Finch Therapeutics Group, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI
12.03. Top Absteiger vorbörslich MT

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Finch Therapeutics Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Top Premarket Decliners
North American Morning Briefing : Stocks Seen -2-
Finch Therapeutics Group, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Acurx Pharmaceuticals Share Price And Volume Are Surging Ahead Of Phase 2b Trial Data Release ($ACXP)
North American Morning Briefing : Stock Futures -2-
Finch Therapeutics Group, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Finch Therapeutics Group, Inc. Announces Resignation of Nicholas Haft as Member of Board
Finch Therapeutics Group, Inc.(NasdaqGS:FNCH) dropped from Russell Microcap Index
Finch Therapeutics Group, Inc.(NasdaqGS:FNCH) dropped from Russell Microcap Value Index
Finch Therapeutics Group, Inc.(NasdaqGS:FNCH) dropped from Russell 3000E Value Index
Finch Therapeutics Group, Inc.(NasdaqGS:FNCH) dropped from Russell 3000E Index
Top Premarket Decliners
Finch Therapeutics Group Slumps Almost 15% in Premarket Tuesday
FINCH THERAPEUTICS GROUP, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)
Finch Therapeutics Group to Implement 1-for-30 Reverse Stock Split
Finch Announces Reverse Stock Split of Common Stock
Finch Announces Reverse Stock Split of Common Stock
FINCH THERAPEUTICS GROUP, INC. : Change in Directors or Principal Officers (form 8-K)
FINCH THERAPEUTICS GROUP, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3EFQ9 Aktie
  4. Nachrichten Finch Therapeutics Group, Inc.
  5. Andere Sprachen